The anti-inflammatory and restorative effects of the flavonoid-enriched fraction AF4 were examined in a mouse model of experimental autoimmune encephalomyelitis (EAE). Relative to EAE mice that received vehicle (water, 10 ml/kg/day), oral administration of AF4 (25 mg/kg/day) beginning 24 hours after the onset of clinical signs reduced disease progression that was accompanied by diminished pro-inflammatory cytokine gene expression (cerebellum and spinal cord) and protein concentrations in the plasma. LPS-induced release of TNF-? from the whole blood of EAE mice that received AF4 was reduced at peak disease severity (day 18) but not once central inflammation had declined (day 31) indicative of unique immune modulator properties. Lastly, the expression of myelin-associated genes (PGC-1?, SCD1, and MBP) suggestive of remyelination was enhanced in the spinal cord of EAE mice that received AF4. These findings suggest that AF4 reduces EAE severity by selectively inhibiting autoimmunity and enhancing the expression of genes necessary for remyelination.
| Identifer | oai:union.ndltd.org:LACETR/oai:collectionscanada.gc.ca:NSHD.ca#10222/44680 |
| Date | 04 December 2012 |
| Creators | Warford, Jordan R. |
| Source Sets | Library and Archives Canada ETDs Repository / Centre d'archives des thèses électroniques de Bibliothèque et Archives Canada |
| Language | English |
| Detected Language | English |
Page generated in 0.002 seconds